리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 08월
페이지 정보:영문 369 Pages
라이선스 & 가격 (부가세 별도)
한글목차
바이오의약품 크로마토그래피 시스템 세계 시장은 2030년까지 53억 달러에 달할 전망
2024년에 33억 달러로 추정되는 바이오의약품 크로마토그래피 시스템 세계 시장은 2024년부터 2030년까지 CAGR 8.1%로 성장하여 2030년에는 53억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 일회용 시스템은 CAGR 9.1%를 기록하며 분석 기간 종료시에는 40억 달러에 달할 것으로 예측됩니다. 다회용 시스템 부문의 성장률은 분석 기간 동안 CAGR 5.3%로 추정됩니다.
미국 시장은 추정 9억 830만 달러, 중국은 CAGR 12.7%로 성장 예측
미국의 바이오의약품 크로마토그래피 시스템 시장은 2024년에 9억 830만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 12억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 12.7%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 4.0%와 7.8%로 예측됩니다. 유럽에서는 독일이 CAGR 5.4%로 성장할 것으로 예측됩니다.
세계의 바이오의약품 크로마토그래피 시스템 시장 - 주요 동향과 촉진요인 정리
바이오의약품 제조 공정에서 크로마토그래피 시스템이 중요한 이유는 무엇인가?
바이오의약품 제조에 요구되는 복잡성과 정밀도가 증가함에 따라 크로마토그래피 시스템은 제품의 순도, 유효성 및 규제 준수를 보장하는 데 필수적인 도구가 되었습니다. 단클론항체, 백신, 호르몬, 세포 기반 치료제와 같은 바이오의약품의 개발 및 제조에서 크로마토그래피는 생체분자의 분리, 정제, 분석에 중요한 역할을 합니다. 기존 의약품과 달리 바이오의약품은 생물체에서 생산되기 때문에 그 구성이 더 다양하고 정제가 매우 어렵습니다. 크로마토그래피 시스템은 단백질, 핵산, 기타 생물학적 물질을 세포 잔류물, 숙주 세포 단백질, 불순물로부터 매우 미세한 수준에서 선택적으로 분리할 수 있습니다. 이를 통해 최종 제품의 안전성과 일관성을 보장합니다. 이는 환자 결과와 FDA, EMA, WHO 등 규제기관이 정한 엄격한 기준을 충족하기 위해 매우 중요합니다. 또한, 크로마토그래피를 실험실에서 상업 생산까지 확장할 수 있기 때문에 바이오 제약사는 다양한 생산 단계에서 품질 관리를 유지하면서 의약품 개발 기간을 단축할 수 있습니다. 대용량 수지 및 모놀리식 컬럼과 같은 크로마토그래피 매체의 혁신은 시스템의 성능, 처리량, 재현성을 더욱 향상시키고 있습니다. 바이오의약품 산업은 맞춤형 의료와 생물학적 제제에 대한 수요 증가에 힘입어 그 규모와 복잡성이 지속적으로 확대되고 있습니다. 크로마토그래피 시스템은 신뢰할 수 있는 고순도 제조 워크플로우의 핵심 기술입니다.
기술 혁신은 바이오의약품 크로마토그래피 시스템의 성능을 어떻게 향상시키고 있는가?
기술의 발전은 바이오의약품 크로마토그래피 시스템을 더 빠르고, 더 정확하고, 더 자동화하여 현대 생물학적 제제 제조의 진화하는 요구에 부응할 수 있도록 변화시키고 있습니다. 기술 혁신의 가장 중요한 분야 중 하나는 일회용 크로마토그래피 시스템의 개발로 교차 오염의 위험을 줄이고 세척 검증 요구 사항을 최소화하며 작동 유연성을 향상시키는 것입니다. 이러한 시스템은 빠른 전환이 요구되는 다품종 생산 시설에서 특히 유용합니다. 자동화 및 디지털 통합은 실시간 모니터링, 고급 데이터 분석, 원격 프로세스 제어를 가능하게함으로써 크로마토그래피 운영에도 혁명을 불러일으키고 있습니다. 소프트웨어 기반 플랫폼을 통해 제조업체는 높은 정밀도로 매개 변수를 미세 조정할 수 있으며, 정제 결과의 일관성을 높이고 배치 결함을 줄일 수 있습니다. 또한, 기존의 배치 방식과 달리 연속 크로마토그래피는 처리량 향상, 수지 비용 절감, 공정 효율의 향상이 가능하다는 점에서 지지를 받고 있습니다. 수지화학의 혁신은 복잡한 생체분자나 저수율 생체분자를 정제하는 데 필수적인 더 높은 선택성과 결합력을 제공하는 리간드의 개발로 이어지고 있습니다. 또한, 컬럼 설계와 유량분배 기술의 개선으로 더 뛰어난 확장성과 처리시간 단축이 가능해졌습니다. 이온교환, 친수성, 소수성 상호작용 크로마토그래피를 통합 워크플로우에 통합한 하이브리드 시스템도 널리 보급되고 있으며, 다양한 생체분자를 다루는 데 있어 더 높은 유연성과 견고성을 제공합니다. 이러한 기술 혁신은 성능 향상을 촉진할 뿐만 아니라, 바이오의약품 제조업체가 더 엄격한 규제 요건을 충족하고 변화하는 치료 수요에 더 빠르게 대응할 수 있도록 돕고 있습니다.
바이오의약품의 크로마토그래피 시스템 채택을 촉진하는 지역 및 업계 동향은 무엇인가?
바이오 제약 분야의 크로마토그래피 시스템 채택 및 맞춤화에는 지역적 역학 및 특정 산업 요구사항이 매우 중요한 역할을 합니다. 생물학적 제제 개발이 성숙하고 규제가 엄격한 북미와 유럽에서는 높은 처리량, 자동화, 규제 준수가 가능한 첨단 크로마토그래피 플랫폼에 대한 투자가 활발히 이루어지고 있습니다. 대형 제약사, 위탁생산기관(CMO), 잘 구축된 R&D 인프라의 존재는 이들 시장에서 크로마토그래피의 지속적인 활용 확대를 뒷받침하고 있습니다. 또한, 이들 지역에서는 바이오시밀러 및 제네릭 바이오의약품에 대한 수요가 증가하고 있으며, 비용 효율적이고 확장성이 높은 정제 기술의 도입이 더욱 가속화되고 있습니다. 반면, 아시아태평양, 특히 중국, 인도, 한국은 바이오의약품 제조에 대한 정부 지원, 외국인 투자 증가, 국내 의약품 시장 성장에 힘입어 빠른 성장세를 보이고 있습니다. 이들 국가는 엔드 투 엔드 바이오 생산능력 구축에 주력하고 있으며, 크로마토그래피 시스템은 바이오 공정 전략의 핵심 요소로 자리 잡고 있습니다. 한편, 라틴아메리카와 중동은 유망한 지역으로 부상하고 있으며, 각국의 보건의료 개혁과 생물학적 제제의 현지 생산에 대한 관심이 높아지면서 바이오 제조 인프라에 대한 투자를 촉진하고 있습니다. 맞춤형 의료, 세포 및 유전자 치료, 팬데믹 대응에 대한 관심이 높아지면서 다양한 종류의 생체분자에 쉽게 적응할 수 있는 유연한 모듈식 크로마토그래피 시스템에 대한 관심이 높아지고 있습니다. 이러한 지역적 다양성으로 인해 크로마토그래피 시스템 세계 시장은 매우 역동적이고 세분화되어 있으며, 기존 기업이나 신규 진입 기업 모두 지역적 요구와 규제에 따라 성장 기회를 찾고 있습니다.
바이오의약품 크로마토그래피 시스템의 세계 성장을 가속화하는 요인은 무엇일까?
바이오의약품 크로마토그래피 시스템 시장의 성장은 치료법 혁신, 규제 진화, 기술 발전, 바이오 제조의 확장성과 관련된 몇 가지 중요한 요인에 의해 주도되고 있습니다. 주요 성장 요인은 암, 자가면역질환, 희귀유전질환 등 만성질환 및 생명을 위협하는 질환의 치료에 사용되는 생물학적 제제에 대한 수요 증가가 주요 성장 요인으로 작용하고 있습니다. 개발 중인 생물학적 제제의 수가 계속 증가함에 따라 품질과 생산량 요구 사항을 모두 충족시킬 수 있는 신뢰할 수 있는 고처리량 정제 기술에 대한 요구도 증가하고 있습니다. 또 다른 중요한 요인은 바이오의약품이 복잡해지면서 제품의 무결성을 손상시키지 않고 광범위한 공정과 관련된 불순물을 제거할 수 있는 보다 진보된 정제 기술이 요구되고 있다는 점입니다. 규제 당국도 품질에 대한 기대치를 높이고 있으며, 제조업체는 보다 높은 수준의 관리, 추적성, 문서화를 실현할 수 있는 시스템을 도입해야 합니다. 일회용 기술, 연속 처리, 공정 분석 기술(PAT)의 발전으로 제조업체는 생산성 향상, 비용 절감, 시장 출시 속도 향상을 실현하고 있습니다. 또한, 특히 개별화 치료 및 소량 생산과 같은 분산형 및 민첩한 제조 모델로의 전환은 모듈식 및 유연한 크로마토그래피 셋업에 대한 수요를 창출하고 있습니다. 바이오제약 업계에서는 위탁생산과 아웃소싱이 확대되고 있으며, 서비스 제공업체들이 고도의 정제 능력으로 차별화를 꾀하고 있기 때문에 그 채택이 더욱 가속화되고 있습니다. 마지막으로, 특히 팬데믹과 같은 세계 보건 위협에 대응하기 위해 생물학적 제제에 대한 공공 및 민간의 투자로 인해 확장 가능하고 적응력이 뛰어난 크로마토그래피 솔루션의 필요성이 증가하고 있습니다. 이러한 요인들이 복합적으로 작용하여 세계 바이오의약품 크로마토그래피 시스템 시장은 견고하고 지속적인 성장세를 보이고 있습니다.
부문
시스템 유형(일회용 시스템, 다회용 시스템), 미디어 유형(액체 미디어 유형, 가스 미디어 유형), 최종사용자(바이오 제약 기업 최종사용자, 생명과학 및 학술 연구 최종사용자, CMO 최종사용자)
조사 대상 기업 사례
Agilent Technologies
Avantor Inc.
Bio-Rad Laboratories Inc.
Bionetix Inc.
Cytiva(Danaher Corporation)
Ecolab Life Sciences
Eppendorf SE
GE Healthcare Life Sciences(now part of Cytiva)
Hitachi High-Tech Corporation
Knauer Wissenschaftliche Gerate
Merck KGaA(MilliporeSigma in US)
Mitsubishi Chemical Corporation
PerkinElmer Inc.
Phenomenex Inc.
Purolite(an Ecolab Company)
Repligen Corporation
Sartorius AG
Shimadzu Corporation
Thermo Fisher Scientific Inc.
Tosoh Bioscience LLC
AI 통합
Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.
Global Industry Analysts는 일반적인 LLM 및 업계 고유의 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가가 선별한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트
기타 중동
아프리카
제4장 경쟁
KSM
영문 목차
영문목차
Global Biopharma Chromatography Systems Market to Reach US$5.3 Billion by 2030
The global market for Biopharma Chromatography Systems estimated at US$3.3 Billion in the year 2024, is expected to reach US$5.3 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Single-Use Systems, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$4.0 Billion by the end of the analysis period. Growth in the Multi-Use Systems segment is estimated at 5.3% CAGR over the analysis period.
The U.S. Market is Estimated at US$908.3 Million While China is Forecast to Grow at 12.7% CAGR
The Biopharma Chromatography Systems market in the U.S. is estimated at US$908.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 12.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.0% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.
Global Biopharma Chromatography Systems Market - Key Trends & Drivers Summarized
Why Are Chromatography Systems Crucial to the Biopharmaceutical Manufacturing Process?
The increasing complexity and precision required in biopharmaceutical production have elevated chromatography systems as essential tools for ensuring product purity, efficacy, and regulatory compliance. In the development and manufacturing of biologics, including monoclonal antibodies, vaccines, hormones, and cell-based therapies, chromatography plays a critical role in the separation, purification, and analysis of biomolecules. Unlike traditional pharmaceuticals, biopharmaceuticals are produced from living organisms, making their composition more variable and their purification significantly more challenging. Chromatography systems allow for the selective separation of proteins, nucleic acids, and other biological substances from cell debris, host cell proteins, and impurities, often at very fine levels of distinction. This ensures the safety and consistency of the final product, which is crucial for patient outcomes and meeting the strict standards set by regulatory bodies such as the FDA, EMA, and WHO. Moreover, the ability to scale chromatography from lab to commercial manufacturing supports biopharma companies in speeding up drug development timelines while maintaining quality control across different production stages. Innovations in chromatography media, such as high-capacity resins and monolithic columns, are further enhancing system performance, throughput, and reproducibility. As the biopharma industry continues to grow in both size and complexity, driven by increasing demand for personalized medicine and biologic drugs, chromatography systems remain a backbone technology for reliable, high-purity production workflows.
How Are Technological Innovations Advancing the Performance of Biopharma Chromatography Systems?
Advancements in technology are transforming biopharma chromatography systems, making them faster, more precise, and increasingly automated to meet the evolving needs of modern biologic drug production. One of the most significant areas of innovation is the development of single-use chromatography systems, which reduce cross-contamination risk, minimize cleaning validation requirements, and increase operational flexibility. These systems are particularly valuable in multiproduct facilities where rapid changeovers are required. Automation and digital integration are also revolutionizing chromatography operations by enabling real-time monitoring, advanced data analytics, and remote process control. Through software-driven platforms, manufacturers can now fine-tune parameters with high accuracy, leading to more consistent purification results and reduced batch failures. Furthermore, continuous chromatography, as opposed to traditional batch methods, is gaining traction for its ability to improve throughput, lower resin costs, and increase process efficiency. Innovations in resin chemistry are leading to the development of ligands that offer higher selectivity and binding capacity, which is critical for purifying complex or low-yield biomolecules. In addition, improvements in column design and flow distribution technology are allowing for better scalability and reduced processing times. Hybrid systems that combine ion exchange, affinity, and hydrophobic interaction chromatography in integrated workflows are also becoming more prevalent, offering greater flexibility and robustness in handling diverse biomolecules. These innovations are not only driving performance enhancements but also helping biopharma manufacturers meet tighter regulatory requirements and respond more swiftly to changing therapeutic demands.
What Regional and Industry Trends Are Driving Adoption of Chromatography Systems in Biopharma?
Regional dynamics and specific industry needs are playing a pivotal role in the adoption and customization of chromatography systems in the biopharmaceutical sector. In North America and Europe, where biologic drug development is mature and heavily regulated, there is significant investment in advanced chromatography platforms capable of high throughput, automation, and regulatory compliance. The presence of major pharmaceutical companies, contract manufacturing organizations (CMOs), and well-established R&D infrastructure supports the continued expansion of chromatography usage in these markets. Additionally, increasing demand for biosimilars and generic biologics in these regions is further encouraging the deployment of cost-effective and scalable purification technologies. In contrast, the Asia-Pacific region, particularly China, India, and South Korea, is witnessing rapid growth driven by government support for biopharma manufacturing, increasing foreign investments, and a growing domestic pharmaceutical market. These countries are focusing on building end-to-end bioproduction capabilities, with chromatography systems being a central component of their bioprocessing strategies. Meanwhile, Latin America and the Middle East are emerging as promising regions, where national healthcare reforms and an expanding focus on local biologics production are driving investments in biomanufacturing infrastructure. Across all regions, a growing emphasis on personalized medicine, cell and gene therapies, and pandemic preparedness is shifting focus toward flexible and modular chromatography systems that can be easily adapted for different types of biomolecules. These diverse regional trends are creating a highly dynamic and segmented global market for chromatography systems, with both established players and new entrants finding growth opportunities tailored to local needs and regulations.
What Forces Are Accelerating the Global Growth of Biopharma Chromatography Systems?
The growth in the biopharma chromatography systems market is driven by several critical factors linked to therapeutic innovation, regulatory evolution, technological advancement, and biomanufacturing scalability. A primary growth driver is the rising demand for biologic drugs, which are increasingly used to treat chronic and life-threatening conditions such as cancer, autoimmune disorders, and rare genetic diseases. As the number of biologics in development continues to grow, so too does the need for reliable, high-throughput purification technologies that can meet both quality and production volume requirements. Another key factor is the growing complexity of biopharmaceutical products, which demands more sophisticated purification techniques capable of removing a wide range of process-related impurities without compromising product integrity. Regulatory agencies are also tightening quality expectations, pushing manufacturers to adopt systems that offer higher levels of control, traceability, and documentation. Advances in single-use technology, continuous processing, and process analytical technology (PAT) are enabling manufacturers to improve productivity, reduce costs, and increase speed-to-market. Moreover, the shift toward decentralized and agile manufacturing models, particularly for personalized therapies and smaller batch production, is creating demand for modular, flexible chromatography setups. The expansion of contract manufacturing and outsourcing trends within the biopharma industry is further fueling adoption, as service providers seek to differentiate themselves with advanced purification capabilities. Finally, public and private sector investment in biologics, particularly in response to global health threats such as pandemics, is reinforcing the need for scalable and adaptable chromatography solutions. Together, these factors are driving robust and sustained growth in the global biopharma chromatography systems market.
SCOPE OF STUDY:
The report analyzes the Biopharma Chromatography Systems market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
System Type (Single-Use Systems, Multi-Use Systems); Media Type (Liquid Media Type, Gas Media Type); End-Use (Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use, CMO End-Use)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 42 Featured) -
Agilent Technologies
Avantor Inc.
Bio-Rad Laboratories Inc.
Bionetix Inc.
Cytiva (Danaher Corporation)
Ecolab Life Sciences
Eppendorf SE
GE Healthcare Life Sciences (now part of Cytiva)
Hitachi High-Tech Corporation
Knauer Wissenschaftliche Gerate
Merck KGaA (MilliporeSigma in US)
Mitsubishi Chemical Corporation
PerkinElmer Inc.
Phenomenex Inc.
Purolite (an Ecolab Company)
Repligen Corporation
Sartorius AG
Shimadzu Corporation
Thermo Fisher Scientific Inc.
Tosoh Bioscience LLC
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Tariff Impact on Global Supply Chain Patterns
Biopharma Chromatography Systems - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Booming Biologics and Biosimilars Market Throws the Spotlight on High-Precision Chromatography Systems
Rising Demand for Monoclonal Antibodies Spurs Growth in Large-Scale Chromatographic Purification Solutions
Here's the Story: How Single-Use Technologies Are Transforming Chromatography System Design in Biopharma
Expansion of Contract Manufacturing Organizations (CMOs) Expands Addressable Market for Modular Chromatography Systems
Increased Investment in Cell and Gene Therapies Drives Demand for Customizable Separation Technologies
Growing Adoption of Continuous Bioprocessing Spurs Innovation in Integrated Chromatography Workflows
Here's How High-Throughput Screening and Process Intensification Are Reshaping System Requirements
Surging Vaccine Development and Manufacturing Accelerates Global Deployment of Chromatography Equipment
Automation and Digitalization Trends Throw the Spotlight on Smart and Software-Enabled Chromatography Systems
Rising Interest in Green Chemistry and Sustainable Bioprocessing Generates Demand for Eco-Friendly Chromatography Media
Evolving Analytical Requirements in Downstream Processing Create Opportunities for Hybrid and Multi-Modal Chromatography Systems
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Biopharma Chromatography Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Biopharma Chromatography Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 4: World 16-Year Perspective for Biopharma Chromatography Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Single-Use Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Single-Use Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 7: World 16-Year Perspective for Single-Use Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Multi-Use Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Multi-Use Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 10: World 16-Year Perspective for Multi-Use Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Liquid Media Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Liquid Media Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 13: World 16-Year Perspective for Liquid Media Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Gas Media Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Gas Media Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 16: World 16-Year Perspective for Gas Media Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Biopharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 19: World 16-Year Perspective for Biopharmaceutical Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Life Sciences & Academic Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Life Sciences & Academic Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 22: World 16-Year Perspective for Life Sciences & Academic Research End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for CMO End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 24: World Historic Review for CMO End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 25: World 16-Year Perspective for CMO End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 26: USA Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 27: USA Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 28: USA 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 29: USA Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 30: USA Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 31: USA 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 33: USA Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 34: USA 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
CANADA
TABLE 35: Canada Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 36: Canada Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 37: Canada 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 38: Canada Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 40: Canada 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 41: Canada Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 42: Canada Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 43: Canada 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
JAPAN
Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 44: Japan Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: Japan Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 46: Japan 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 47: Japan Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 48: Japan Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 49: Japan 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 50: Japan Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: Japan Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 52: Japan 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
CHINA
Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 53: China Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 54: China Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 55: China 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 56: China Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: China Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 58: China 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 59: China Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 60: China Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 61: China 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
EUROPE
Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 62: Europe Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 63: Europe Historic Review for Biopharma Chromatography Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 64: Europe 16-Year Perspective for Biopharma Chromatography Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
TABLE 65: Europe Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 66: Europe Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 67: Europe 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 68: Europe Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: Europe Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 70: Europe 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 71: Europe Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 73: Europe 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
FRANCE
Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 74: France Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: France Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 76: France 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 77: France Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 78: France Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 79: France 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 80: France Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: France Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 82: France 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
GERMANY
Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 83: Germany Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 84: Germany Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 85: Germany 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 86: Germany Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Germany Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 88: Germany 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 89: Germany Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: Germany Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 91: Germany 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
ITALY
TABLE 92: Italy Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: Italy Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 94: Italy 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 95: Italy Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 96: Italy Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 97: Italy 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 98: Italy Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: Italy Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 100: Italy 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
UNITED KINGDOM
Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 101: UK Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 102: UK Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 103: UK 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 104: UK Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: UK Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 106: UK 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 107: UK Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 108: UK Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 109: UK 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
SPAIN
TABLE 110: Spain Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: Spain Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 112: Spain 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 113: Spain Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 114: Spain Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 115: Spain 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 116: Spain Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: Spain Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 118: Spain 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
RUSSIA
TABLE 119: Russia Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 120: Russia Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 121: Russia 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 122: Russia Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 123: Russia Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 124: Russia 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 125: Russia Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 126: Russia Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 127: Russia 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
REST OF EUROPE
TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 129: Rest of Europe Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 130: Rest of Europe 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 132: Rest of Europe Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 133: Rest of Europe 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 135: Rest of Europe Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 136: Rest of Europe 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
ASIA-PACIFIC
Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 138: Asia-Pacific Historic Review for Biopharma Chromatography Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 139: Asia-Pacific 16-Year Perspective for Biopharma Chromatography Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 141: Asia-Pacific Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 142: Asia-Pacific 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 144: Asia-Pacific Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 145: Asia-Pacific 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 147: Asia-Pacific Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 148: Asia-Pacific 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
AUSTRALIA
Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 149: Australia Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 150: Australia Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 151: Australia 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 152: Australia Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 153: Australia Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 154: Australia 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 155: Australia Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 156: Australia Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 157: Australia 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
INDIA
Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 158: India Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 159: India Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 160: India 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 161: India Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 162: India Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 163: India 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 164: India Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 165: India Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 166: India 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
SOUTH KOREA
TABLE 167: South Korea Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 168: South Korea Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 169: South Korea 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 170: South Korea Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 171: South Korea Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 172: South Korea 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 173: South Korea Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 174: South Korea Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 175: South Korea 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 177: Rest of Asia-Pacific Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 180: Rest of Asia-Pacific Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 183: Rest of Asia-Pacific Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
LATIN AMERICA
Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 185: Latin America Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 186: Latin America Historic Review for Biopharma Chromatography Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 187: Latin America 16-Year Perspective for Biopharma Chromatography Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
TABLE 188: Latin America Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 189: Latin America Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 190: Latin America 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 191: Latin America Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 192: Latin America Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 193: Latin America 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 194: Latin America Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 195: Latin America Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 196: Latin America 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
ARGENTINA
TABLE 197: Argentina Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 198: Argentina Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 199: Argentina 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 200: Argentina Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 201: Argentina Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 202: Argentina 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 203: Argentina Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 204: Argentina Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 205: Argentina 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
BRAZIL
TABLE 206: Brazil Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 207: Brazil Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 208: Brazil 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 209: Brazil Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 210: Brazil Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 211: Brazil 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 212: Brazil Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 213: Brazil Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 214: Brazil 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
MEXICO
TABLE 215: Mexico Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 216: Mexico Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 217: Mexico 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 218: Mexico Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 219: Mexico Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 220: Mexico 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 221: Mexico Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 222: Mexico Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 223: Mexico 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
REST OF LATIN AMERICA
TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 225: Rest of Latin America Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 226: Rest of Latin America 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 228: Rest of Latin America Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 229: Rest of Latin America 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 231: Rest of Latin America Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 232: Rest of Latin America 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
MIDDLE EAST
Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 233: Middle East Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 234: Middle East Historic Review for Biopharma Chromatography Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 235: Middle East 16-Year Perspective for Biopharma Chromatography Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
TABLE 236: Middle East Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 237: Middle East Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 238: Middle East 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 239: Middle East Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 240: Middle East Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 241: Middle East 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 242: Middle East Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 243: Middle East Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 244: Middle East 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
IRAN
TABLE 245: Iran Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 246: Iran Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 247: Iran 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 248: Iran Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 249: Iran Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 250: Iran 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 251: Iran Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 252: Iran Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 253: Iran 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
ISRAEL
TABLE 254: Israel Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 255: Israel Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 256: Israel 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 257: Israel Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 258: Israel Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 259: Israel 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 260: Israel Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 261: Israel Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 262: Israel 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
SAUDI ARABIA
TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 264: Saudi Arabia Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 265: Saudi Arabia 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 267: Saudi Arabia Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 268: Saudi Arabia 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 270: Saudi Arabia Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 271: Saudi Arabia 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 272: UAE Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 273: UAE Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 274: UAE 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 275: UAE Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 276: UAE Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 277: UAE 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 278: UAE Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 279: UAE Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 280: UAE 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
REST OF MIDDLE EAST
TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 282: Rest of Middle East Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 283: Rest of Middle East 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 285: Rest of Middle East Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 286: Rest of Middle East 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 288: Rest of Middle East Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 289: Rest of Middle East 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030
AFRICA
Biopharma Chromatography Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 290: Africa Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 291: Africa Historic Review for Biopharma Chromatography Systems by System Type - Single-Use Systems and Multi-Use Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 292: Africa 16-Year Perspective for Biopharma Chromatography Systems by System Type - Percentage Breakdown of Value Sales for Single-Use Systems and Multi-Use Systems for the Years 2014, 2025 & 2030
TABLE 293: Africa Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 294: Africa Historic Review for Biopharma Chromatography Systems by Media Type - Liquid Media Type and Gas Media Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 295: Africa 16-Year Perspective for Biopharma Chromatography Systems by Media Type - Percentage Breakdown of Value Sales for Liquid Media Type and Gas Media Type for the Years 2014, 2025 & 2030
TABLE 296: Africa Recent Past, Current & Future Analysis for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 297: Africa Historic Review for Biopharma Chromatography Systems by End-Use - Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
TABLE 298: Africa 16-Year Perspective for Biopharma Chromatography Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies End-Use, Life Sciences & Academic Research End-Use and CMO End-Use for the Years 2014, 2025 & 2030